Allogene Therapeutics, Inc. (ALLO)
1.325
0.00 (0.00%)
USD |
NASDAQ |
Oct 21, 16:00
1.325
0.00 (0.00%)
After-Hours: 20:00
Allogene Therapeutics Profit Margin (Quarterly) : -919.8% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -919.8% |
| March 31, 2026 | |
| December 31, 2025 | |
| September 30, 2025 | |
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | -295.5K% |
| December 31, 2023 | -408.5K% |
| Date | Value |
|---|---|
| September 30, 2023 | -283.1K% |
| June 30, 2023 | -360.1K% |
| March 31, 2023 | -333.2K% |
| December 31, 2022 | -201.8K% |
| September 30, 2022 | -169.7K% |
| June 30, 2022 | -86.96K% |
| March 31, 2022 | -130.9K% |
| December 31, 2021 | -146.8K% |
| September 30, 2021 | -159.6K% |
| June 30, 2021 | -161.2K% |
| March 31, 2021 | -86.10% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -237.8% |
| Oncolytics Biotech, Inc. | -- |
| Sangamo Therapeutics, Inc. | -2.15K% |
| Sarepta Therapeutics, Inc. | -1.22% |
| Anixa Biosciences, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -49.62% |
| Return on Assets | -36.42% |
| Return on Invested Capital | -39.73% |
| Gross Profit Margin (Quarterly) | 43.00% |
| Operating Margin (Quarterly) | -1.01K% |
| Return on Net Operating Assets | -146.6% |